Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: A 2-institution study

Masaaki Yamamoto, Toru Serizawa, Yoshinori Higuchi, Osamu Nagano, Hitoshi Aiyama, Takao Koiso, Shinya Watanabe, Takuya Kawabe, Yasunori Sato, Hidetoshi Kasuya

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

OBJECTIVE With the aging of the population, increasing numbers of elderly patients with brain metastasis (BM) are undergoing stereotactic radiosurgery (SRS). Among recently reported prognostic grading indexes, only the basic score for brain metastases (BSBM) is applicable to patients 65 years or older. However, the major weakness of this system is that no BM-related factors are graded. This prompted the authors to develop a new grading system, the elderly-specific (ES)–BSBM. METHODS For this IRB-approved, retrospective cohort study, the authors used their prospectively accumulated database comprising 3267 consecutive patients undergoing Gamma Knife SRS for BMs during the 1998–2016 period at the Mito GammaHouse. Among these 3267 patients, 1789 patients ≥ 65 years of age were studied (Yamamoto series [Y-series]). Another series of 1785 patients ≥ 65 years of age in whom Serizawa and colleagues performed Gamma Knife SRS during the same period (Serizawa series [S-series]) was used for validity testing of the ES-BSBM. RESULTS Two factors were identified as strongly impacting longer survival after SRS by means of multivariable analysis using the Cox proportional hazard model with a stepwise selection procedure. These factors are the number of tumors (solitary vs multiple: HR 1.450, 95% CI 1.299–1.621; p < 0.0001) and cumulative tumor volume (≤ 15 cm 3 vs > 15 cm 3 : HR 1.311, 95% CI 1.078–1.593; p = 0.0067). The new index is the addition of scores 0 and 1 for these 2 factors to the BSBM. The ES-BSBM system is based on categorization into 3 classes by adding these 2 scores to those of the original BSBM. Each ES-BSBM category has 2 possible scores. For the category ES-BSBM 4–5, the score is either 4 or 5; for ES-BSBM 2–3, the score is either 2 or 3; and for ES-BSBM 0–1, the score is either 0 or 1. In the Y-series, the median survival times (MSTs, months) after SRS were 17.5 (95% CI 15.4–19.3) in ES-BSBM 4–5, 6.9 (95% CI 6.4–7.4) in ES-BSBM 2–3, and 2.8 (95% CI 2.5–3.6) in ES-BSBM 0–1 (p < 0.0001). Also, in the S-series, MSTs were, respectively, 20.4 (95% CI 17.2–23.4), 7.9 (95% CI 7.4–8.5), and 3.2 (95% CI 2.8–3.6) (p < 0.0001). The ES-BSBM system was shown to be applicable to patients with all primary tumor types as well as to those 80 years or older. CONCLUSIONS The authors found that the addition of the number of tumors and cumulative tumor volume as scoring factors to the BSBM system significantly improved the prognostic value of this index. The present study is strengthened by testing the ES-BSBM in a different patient group.

Original languageEnglish
Pages (from-to)95-102
Number of pages8
JournalJournal of neurosurgery
Volume129
DOIs
Publication statusPublished - 2018 Dec 1
Externally publishedYes

Fingerprint

Radiosurgery
varespladib methyl
Neoplasm Metastasis
Brain
Tumor Burden
Neoplasms
Survival
Research Ethics Committees

Keywords

  • Brain metastases
  • Elderly patients
  • Gamma Knife
  • Oncology
  • Prognostic index
  • Radiation therapy
  • Stereotactic radiosurgery

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery : A 2-institution study. / Yamamoto, Masaaki; Serizawa, Toru; Higuchi, Yoshinori; Nagano, Osamu; Aiyama, Hitoshi; Koiso, Takao; Watanabe, Shinya; Kawabe, Takuya; Sato, Yasunori; Kasuya, Hidetoshi.

In: Journal of neurosurgery, Vol. 129, 01.12.2018, p. 95-102.

Research output: Contribution to journalArticle

Yamamoto, M, Serizawa, T, Higuchi, Y, Nagano, O, Aiyama, H, Koiso, T, Watanabe, S, Kawabe, T, Sato, Y & Kasuya, H 2018, 'Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: A 2-institution study', Journal of neurosurgery, vol. 129, pp. 95-102. https://doi.org/10.3171/2018.7.GKS181458
Yamamoto, Masaaki ; Serizawa, Toru ; Higuchi, Yoshinori ; Nagano, Osamu ; Aiyama, Hitoshi ; Koiso, Takao ; Watanabe, Shinya ; Kawabe, Takuya ; Sato, Yasunori ; Kasuya, Hidetoshi. / Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery : A 2-institution study. In: Journal of neurosurgery. 2018 ; Vol. 129. pp. 95-102.
@article{3836e9aed5a44d8db3b68f4c3735b04b,
title = "Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: A 2-institution study",
abstract = "OBJECTIVE With the aging of the population, increasing numbers of elderly patients with brain metastasis (BM) are undergoing stereotactic radiosurgery (SRS). Among recently reported prognostic grading indexes, only the basic score for brain metastases (BSBM) is applicable to patients 65 years or older. However, the major weakness of this system is that no BM-related factors are graded. This prompted the authors to develop a new grading system, the elderly-specific (ES)–BSBM. METHODS For this IRB-approved, retrospective cohort study, the authors used their prospectively accumulated database comprising 3267 consecutive patients undergoing Gamma Knife SRS for BMs during the 1998–2016 period at the Mito GammaHouse. Among these 3267 patients, 1789 patients ≥ 65 years of age were studied (Yamamoto series [Y-series]). Another series of 1785 patients ≥ 65 years of age in whom Serizawa and colleagues performed Gamma Knife SRS during the same period (Serizawa series [S-series]) was used for validity testing of the ES-BSBM. RESULTS Two factors were identified as strongly impacting longer survival after SRS by means of multivariable analysis using the Cox proportional hazard model with a stepwise selection procedure. These factors are the number of tumors (solitary vs multiple: HR 1.450, 95{\%} CI 1.299–1.621; p < 0.0001) and cumulative tumor volume (≤ 15 cm 3 vs > 15 cm 3 : HR 1.311, 95{\%} CI 1.078–1.593; p = 0.0067). The new index is the addition of scores 0 and 1 for these 2 factors to the BSBM. The ES-BSBM system is based on categorization into 3 classes by adding these 2 scores to those of the original BSBM. Each ES-BSBM category has 2 possible scores. For the category ES-BSBM 4–5, the score is either 4 or 5; for ES-BSBM 2–3, the score is either 2 or 3; and for ES-BSBM 0–1, the score is either 0 or 1. In the Y-series, the median survival times (MSTs, months) after SRS were 17.5 (95{\%} CI 15.4–19.3) in ES-BSBM 4–5, 6.9 (95{\%} CI 6.4–7.4) in ES-BSBM 2–3, and 2.8 (95{\%} CI 2.5–3.6) in ES-BSBM 0–1 (p < 0.0001). Also, in the S-series, MSTs were, respectively, 20.4 (95{\%} CI 17.2–23.4), 7.9 (95{\%} CI 7.4–8.5), and 3.2 (95{\%} CI 2.8–3.6) (p < 0.0001). The ES-BSBM system was shown to be applicable to patients with all primary tumor types as well as to those 80 years or older. CONCLUSIONS The authors found that the addition of the number of tumors and cumulative tumor volume as scoring factors to the BSBM system significantly improved the prognostic value of this index. The present study is strengthened by testing the ES-BSBM in a different patient group.",
keywords = "Brain metastases, Elderly patients, Gamma Knife, Oncology, Prognostic index, Radiation therapy, Stereotactic radiosurgery",
author = "Masaaki Yamamoto and Toru Serizawa and Yoshinori Higuchi and Osamu Nagano and Hitoshi Aiyama and Takao Koiso and Shinya Watanabe and Takuya Kawabe and Yasunori Sato and Hidetoshi Kasuya",
year = "2018",
month = "12",
day = "1",
doi = "10.3171/2018.7.GKS181458",
language = "English",
volume = "129",
pages = "95--102",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",

}

TY - JOUR

T1 - Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery

T2 - A 2-institution study

AU - Yamamoto, Masaaki

AU - Serizawa, Toru

AU - Higuchi, Yoshinori

AU - Nagano, Osamu

AU - Aiyama, Hitoshi

AU - Koiso, Takao

AU - Watanabe, Shinya

AU - Kawabe, Takuya

AU - Sato, Yasunori

AU - Kasuya, Hidetoshi

PY - 2018/12/1

Y1 - 2018/12/1

N2 - OBJECTIVE With the aging of the population, increasing numbers of elderly patients with brain metastasis (BM) are undergoing stereotactic radiosurgery (SRS). Among recently reported prognostic grading indexes, only the basic score for brain metastases (BSBM) is applicable to patients 65 years or older. However, the major weakness of this system is that no BM-related factors are graded. This prompted the authors to develop a new grading system, the elderly-specific (ES)–BSBM. METHODS For this IRB-approved, retrospective cohort study, the authors used their prospectively accumulated database comprising 3267 consecutive patients undergoing Gamma Knife SRS for BMs during the 1998–2016 period at the Mito GammaHouse. Among these 3267 patients, 1789 patients ≥ 65 years of age were studied (Yamamoto series [Y-series]). Another series of 1785 patients ≥ 65 years of age in whom Serizawa and colleagues performed Gamma Knife SRS during the same period (Serizawa series [S-series]) was used for validity testing of the ES-BSBM. RESULTS Two factors were identified as strongly impacting longer survival after SRS by means of multivariable analysis using the Cox proportional hazard model with a stepwise selection procedure. These factors are the number of tumors (solitary vs multiple: HR 1.450, 95% CI 1.299–1.621; p < 0.0001) and cumulative tumor volume (≤ 15 cm 3 vs > 15 cm 3 : HR 1.311, 95% CI 1.078–1.593; p = 0.0067). The new index is the addition of scores 0 and 1 for these 2 factors to the BSBM. The ES-BSBM system is based on categorization into 3 classes by adding these 2 scores to those of the original BSBM. Each ES-BSBM category has 2 possible scores. For the category ES-BSBM 4–5, the score is either 4 or 5; for ES-BSBM 2–3, the score is either 2 or 3; and for ES-BSBM 0–1, the score is either 0 or 1. In the Y-series, the median survival times (MSTs, months) after SRS were 17.5 (95% CI 15.4–19.3) in ES-BSBM 4–5, 6.9 (95% CI 6.4–7.4) in ES-BSBM 2–3, and 2.8 (95% CI 2.5–3.6) in ES-BSBM 0–1 (p < 0.0001). Also, in the S-series, MSTs were, respectively, 20.4 (95% CI 17.2–23.4), 7.9 (95% CI 7.4–8.5), and 3.2 (95% CI 2.8–3.6) (p < 0.0001). The ES-BSBM system was shown to be applicable to patients with all primary tumor types as well as to those 80 years or older. CONCLUSIONS The authors found that the addition of the number of tumors and cumulative tumor volume as scoring factors to the BSBM system significantly improved the prognostic value of this index. The present study is strengthened by testing the ES-BSBM in a different patient group.

AB - OBJECTIVE With the aging of the population, increasing numbers of elderly patients with brain metastasis (BM) are undergoing stereotactic radiosurgery (SRS). Among recently reported prognostic grading indexes, only the basic score for brain metastases (BSBM) is applicable to patients 65 years or older. However, the major weakness of this system is that no BM-related factors are graded. This prompted the authors to develop a new grading system, the elderly-specific (ES)–BSBM. METHODS For this IRB-approved, retrospective cohort study, the authors used their prospectively accumulated database comprising 3267 consecutive patients undergoing Gamma Knife SRS for BMs during the 1998–2016 period at the Mito GammaHouse. Among these 3267 patients, 1789 patients ≥ 65 years of age were studied (Yamamoto series [Y-series]). Another series of 1785 patients ≥ 65 years of age in whom Serizawa and colleagues performed Gamma Knife SRS during the same period (Serizawa series [S-series]) was used for validity testing of the ES-BSBM. RESULTS Two factors were identified as strongly impacting longer survival after SRS by means of multivariable analysis using the Cox proportional hazard model with a stepwise selection procedure. These factors are the number of tumors (solitary vs multiple: HR 1.450, 95% CI 1.299–1.621; p < 0.0001) and cumulative tumor volume (≤ 15 cm 3 vs > 15 cm 3 : HR 1.311, 95% CI 1.078–1.593; p = 0.0067). The new index is the addition of scores 0 and 1 for these 2 factors to the BSBM. The ES-BSBM system is based on categorization into 3 classes by adding these 2 scores to those of the original BSBM. Each ES-BSBM category has 2 possible scores. For the category ES-BSBM 4–5, the score is either 4 or 5; for ES-BSBM 2–3, the score is either 2 or 3; and for ES-BSBM 0–1, the score is either 0 or 1. In the Y-series, the median survival times (MSTs, months) after SRS were 17.5 (95% CI 15.4–19.3) in ES-BSBM 4–5, 6.9 (95% CI 6.4–7.4) in ES-BSBM 2–3, and 2.8 (95% CI 2.5–3.6) in ES-BSBM 0–1 (p < 0.0001). Also, in the S-series, MSTs were, respectively, 20.4 (95% CI 17.2–23.4), 7.9 (95% CI 7.4–8.5), and 3.2 (95% CI 2.8–3.6) (p < 0.0001). The ES-BSBM system was shown to be applicable to patients with all primary tumor types as well as to those 80 years or older. CONCLUSIONS The authors found that the addition of the number of tumors and cumulative tumor volume as scoring factors to the BSBM system significantly improved the prognostic value of this index. The present study is strengthened by testing the ES-BSBM in a different patient group.

KW - Brain metastases

KW - Elderly patients

KW - Gamma Knife

KW - Oncology

KW - Prognostic index

KW - Radiation therapy

KW - Stereotactic radiosurgery

UR - http://www.scopus.com/inward/record.url?scp=85057736799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057736799&partnerID=8YFLogxK

U2 - 10.3171/2018.7.GKS181458

DO - 10.3171/2018.7.GKS181458

M3 - Article

C2 - 30544299

AN - SCOPUS:85057736799

VL - 129

SP - 95

EP - 102

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

ER -